SPOTLIGHT -
Exploring the Evolving Treatment Landscape for Advanced Hepatocellular Carcinoma
Andrew X. Zhu, MD, PhD, discusses the evolving treatment landscape for patients with hepatocellular carcinoma.
Advice on Decision Making for Frontline Treatment of HCC
Andrew Zhu, MD, PhD, director of Liver Cancer Research and Medicine at Massachusetts General Hospital, shares his advice on making decisions for frontline treatment of patients with hepatocellular carcinoma.
